Atovaquone
ATC Code
P01AX06
Atovaquone
Definition
A synthetic hydroxynaphthoquinone with antiprotozoal activity. Atovoquone blocks the mitochondrial electron transport at complex III of the respiratory chain of protozoa, thereby inhibiting pyrimidine synthesis, preventing DNA synthesis and leading to protozoal death.
Also known as 566C80, ATOVAQUONE, BW-566C, BW-A566C, Mepron — per NCIT
Also identified as
- ATC P01AX06 per RXNORM
- NCIT NCIT:C28838 per NCIT
- SCTID 108718008 per RXNORM
- SCTID 386899002 per RXNORM
- UNII Y883P1Z2LT per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Cerebral toxoplasmosis | may prevent | MEDRT · Public domain (U.S. Government work) |
| Pneumocystosis | may prevent | MEDRT · Public domain (U.S. Government work) |
| Cerebral toxoplasmosis | may treat | MEDRT · Public domain (U.S. Government work) |
| Pneumocystosis | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Lungs | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Respiratory system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.